List view / Grid view
30 June 2010 | By AstraZeneca
AstraZeneca announced today that Judge Joseph Farnan, Jr., US District Court, District of Delaware, has found that the substance patent protecting CRESTOR (RE37,314 – the ‘314 patent) is valid and enforceable...
29 June 2010 | By Velvet Communications Limited
Aesica Pharmaceuticals has today announced that it has successfully acquired leading research and development company R5...
29 June 2010 | By College Hill Ltd
Molecular Partners AG, announced today the appointment of Dr Göran Ando as independent non-executive member of the board of directors...
28 June 2010 | By AstraZeneca
AstraZeneca and Medicines for Malaria Venture (MMV) today announced a collaborative agreement designed to identify novel candidate drugs for the treatment of malaria...
28 June 2010 | By Johnson & Johnson
OMJPI today announced...
24 June 2010 | By Citigate Dewe Rogerson
Clavis Pharma ASA announces the appointment of Athos Gianella-Borradori MD as Chief Medical Officer...
22 June 2010 | By Nielsen McAllister Public Relations Limited
Pharmaceutical outsourcing specialist Quay Pharma’s new purpose designed laboratories and headquarters have been officially opened by the Deputy First Minister of Wales...
21 June 2010 | By kdm communications limited
Tecan’s systems are providing an integrated solution to researchers at Stanford Genome Technology Center for the study of yeast genomics...
21 June 2010 | By MacDougall Biomedical Communications
Saladax Biomedical, Inc. announced today that it has entered into a multi-year development & commercialization agreement with...
17 June 2010 | By CCA on behalf of Novartis
Data presented at the ECFS Conference in Valencia demonstrate that TIPTM* is as effective as the current standard of care...
15 June 2010 | By Alto Marketing Limited
OGT, has announced the theme and times of its satellite meeting during the European Human Genetics Conference (ESHG) 2010...
15 June 2010 | By Harvey Communications
Where pumping applications involve aggressive, hard-to-handle fluids, the features and benefits of magnetically driven, sealless pumps make them an ideal choice for challenging applications...
10 June 2010 | By Kapler Communications
By combining conventional spectroscopy with sophisticated mapping & imaging technology in its SyNIRgi chemical imaging system & ISys chemical imaging software, Malvern Instruments has...
9 June 2010 | By AD Communications
Brecon Pharmaceuticals, has announced the appointment of Dr Herbert Pomper as Associate Director, European business development...
9 June 2010 | By Citigate Dewe Rogerson
Vantia Therapeutics today announced that it has appointed Andrew Crockett to the position of Chief Executive Officer (CEO)...
